Argenx (ARGX) Outlook Improves on Autoimmune Pipeline Expansion
AI disclosure
Summary
Argenx SE (NASDAQ:ARGX) ranks among the most profitable biotech stocks to buy now. On April 14, TD Cowen maintained its Buy rating and $1,146 price target for A...